DPP-IV inhibitors for treating neurodegeneration and cognitive disorders

Details for Australian Patent Application No. 2009202525 (hide)

Owner Novartis AG

Inventors Hughes, Thomas Edward

Agent Davies Collison Cave

Pub. Number AU-A-2009202525

Parent 2005215136

Filing date 24 June 2009

Wipo publication date 16 July 2009

International Classifications

A61K 31/00 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/4439 (2006.01)

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

Event Publications

9 July 2009 Complete Application Filed

16 July 2009 Application Open to Public Inspection

  Published as AU-A-2009202525

15 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009202526-Secondary Positioning Device for Workpiece Machining

2009202524-Monitoring apparatus